Gen Surg SAQs · surgical-critical-care
Shock after trauma laparotomy — classify the category, defend the fluids, start the right pressor
Fellowship SAQ on surgical shock: four-category classification, EGDT-to-usual-care fluids reasoning, norepinephrine-first pressors, 1:1:1 transfusion, TXA timing gradient and the TBI saline exception.
On this page
Study tools
Target exams
Write your answer
Saved on this device. No marking — you are the marker.
Model answer
(A) Hypovolaemic (haemorrhagic) shock — with obstructive and cardiogenic causes still to exclude (3 marks). Four categories share one mismatch — oxygen supply versus demand — and this is the blood-and-fluids compartment: intravascular volume loss from bleeding, treated by fluid replacement with balanced crystalloids and blood.[1] Cold peripheries, tachycardia, hypotension, oliguria and lactate 4.2 with Hb 82 after laparotomy fit absolute loss, not relative redistribution. Still exclude tamponade/tension physiology (distended veins, muffled sounds, unilateral silence — obstructive shock needs immediate life-saving intervention, never fluids-and-wait) and pump failure before attributing everything to blood loss.[1]
(B) Fluids as tested challenges, norepinephrine first, blood by ratio (4 marks). Continue balanced crystalloid as reassessed challenges with dynamic responsiveness testing — static preload markers are repeatedly unreliable, fluids often give no benefit, and excess harms lungs and kidneys; use cardiac-output/stroke-volume changes from postural manoeuvres or mini-challenges before each bolus.[10][15] Do not chase protocolised venous numbers: PRISM individual data (3,723 patients) found EGDT no better than usual care (24.9% versus 25.4%, odds ratio 0.97) with more ICU days and higher costs.[14] Start norepinephrine early to MAP 65+ rather than dopamine: SOAP II arrhythmia 24.1% versus 12.4% with dopamine, and meta-analysis gives mortality relative risk 0.89 with number needed to treat 9.[22][23] Transfuse 1:1:1 plasma:platelets:red cells — PROPPR showed no 24-hour mortality difference (12.7% versus 17.0%) but less exsanguination death (9.2% versus 14.6%) with more haemostasis and no extra complications.[29]
(C) TXA now, and saline if a head injury coexists (3 marks). Give tranexamic acid 1 g over 10 minutes then 1 g over 8 hours immediately — CRASH-2 (20,211 patients) cut all-cause death (14.5% versus 16.0%, relative risk 0.91) and bleeding death (4.9% versus 5.7%).[30] Timing decides direction: ≤1 hour relative risk 0.68, 1-to-3 hours 0.79, after 3 hours 1.44 harm — at 4 hours post-injury he is outside benefit, so document why TXA is withheld rather than giving it late.[31] If he also had traumatic brain injury, resuscitate with saline not balanced: BEST-Living TBI deaths 19.1% versus 14.7% (odds ratio 1.424) with ESICM conditionally recommending saline over balanced in TBI.[18][19]
References11ShowHide
- [1]Standl T, Annecke T, Cascorbi I, et al. The Nomenclature, Definition and Distinction of Types of Shock. Dtsch Arztebl Int, 2018.PMID 30573009
- [10]Monnet X, Teboul JL Prediction of fluid responsiveness in spontaneously breathing patients. Ann Transl Med, 2020.PMID 32647715
- [14]Rowan KM, Angus DC, Bailey M, Barnato AE, et al. Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis. N Engl J Med, 2017.PMID 28320242
- [15]Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med, 2018.PMID 29485925
- [22]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 2010.PMID 20200382
- [23]Avni T, Lador A, Lev S, Leibovici L, et al. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One, 2015.PMID 26237037
- [29]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
- [30]Shakur H, Roberts I, Bautista R, Caballero J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
- [31]Roberts I, Shakur H, Afolabi A, Brohi K, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
- [18]Zampieri FG, Cavalcanti AB, Di Tanna GL, et al. Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis. Lancet Respir Med, 2024.PMID 38043564
- [19]Arabi YM, Belley-Cote E, Carsetti A, et al. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med, 2024.PMID 38771364